Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20707c031306da1f1265351feea321a1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d014ac91324b942f08107a2d240a87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffe81a999e275d99691b0c138075eb7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35006ae798246ac277262c92fa5191a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d07a021607ade62185f7652e3355a9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b0f0f5c2572ed23a9bb032cee8dc8d |
publicationDate |
2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2623082-C1 |
titleOfInvention |
Method for arterial rigidity correction in patients with rheumatoid arthritis |
abstract |
FIELD: medicine. n SUBSTANCE: method includes introduction of Golimumab at a dose of 50 mg SC 1 times in 4 weeks on the same day to a patient with active disease and ineffectiveness of previous therapy with methotrexate and/or other synthetic DMARDs as a basic anti-inflammatory therapy. n EFFECT: reduction of arterial stiffness in this category of patients due to vasoprotective action of Golimumab both on large elastic-type vessels and small muscle type arteries. n 1 tbl, 1 ex |
priorityDate |
2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |